Pityriasis rubra pilaris after COVID-19 vaccination: successful treatment with ustekinumab.
An Bras Dermatol
; 99(4): 642-644, 2024.
Article
in En
| MEDLINE
| ID: mdl-38653608
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pityriasis Rubra Pilaris
/
Dermatologic Agents
/
Ustekinumab
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
An Bras Dermatol
Year:
2024
Document type:
Article